Page last updated: 2024-08-23

paroxetine and ibogaine

paroxetine has been researched along with ibogaine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ecker, GF; Freissmuth, M; Sarker, S; Sitte, HH; Steiner, I; Sucic, S; Weissensteiner, R1
Garbe, K; Glue, P; Hung, CT; Jakobi, H; Lenagh-Glue, Z; Lyudin, A; Winter, H1

Trials

1 trial(s) available for paroxetine and ibogaine

ArticleYear
Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:6

    Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Half-Life; Healthy Volunteers; Humans; Ibogaine; Male; Paroxetine; Time Factors; Young Adult

2015

Other Studies

1 other study(ies) available for paroxetine and ibogaine

ArticleYear
The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter.
    Molecular pharmacology, 2010, Volume: 78, Issue:6

    Topics: Amphetamines; Antidepressive Agents, Tricyclic; Binding Sites; Carbamazepine; HEK293 Cells; Humans; Ibogaine; Paroxetine; Protein Binding; Serotonin Plasma Membrane Transport Proteins

2010